Previous studies of prostate carcinoma-derived primary spheroid cultures have reported a potential alteration of the molecular biomarker pattern that may include a decline in both AR gene activity and the expression of AR-driven prostate biomarkers [4, 8]. The gene discussed is AR; the disease is prostate carcinoma.